Abstract Objective To investigate the role of short-latency somatosensory evoked potential (SSEP) in the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Methods A total of 48 children with a confirmed or suspected CIDP and 40 healthy children were enrolled. Nerve electrophysiological examination and/or SSEP examination was performed (the children in the healthy control group only underwent SSEP examination). Four-lead electromyography was used for nerve electrophysiological examination, including at least 4 motor nerves and 2 sensory nerves. N6 (elbow potential), N13 (cervical cord potential), and N20 (cortex potential) of the median nerve and N8 (popliteal fossa potential), N22 (lumbar cord potential), and P39 (cortex potential) of the tibial nerve were observed by SSEP examination. Results Among the 48 children with CIDP, 35 had demyelination in both motor and sensory nerves, 8 had demyelination in sensory nerves, and 5 had axonal degeneration. SSEP examination showed that 7 had conduction abnormality in the trunk of the brachial plexus and/or the posterior root and 33 had damage in the lumbosacral plexus and/or the posterior root. The 40 children with abnormal findings of SSEP examination included 8 children with affected sensory nerves and 5 children with secondary axonal degeneration who did not meet the electrophysiological diagnostic criteria for CIDP. Compared with the healthy control group, the CIDP group had significantly prolonged latency periods of N13 and N22 (P Conclusions SSEP can be used for the auxiliary diagnosis of CIDP, especially in CIDP children with affected sensory nerves or secondary axonal degeneration.
SUN Rui-Di,FU Bing,JIANG Jun. Role of short-latency somatosensory evoked potential in the diagnosis of chronic inflammatory demyelinating polyneuropathy[J]. CJCP, 2017, 19(5): 545-548.
SUN Rui-Di,FU Bing,JIANG Jun. Role of short-latency somatosensory evoked potential in the diagnosis of chronic inflammatory demyelinating polyneuropathy[J]. CJCP, 2017, 19(5): 545-548.
Eftimov F, van SI. Chronic inflammatory demyelinating polyradiculoneuropathy:update on clinical features, phenotypes and treatment options[J]. Curr Opin Neurol, 2013, 26(5):496-502.
[2]
Bromberg MB. Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy[J]. Muscle Nerve, 2011, 43(6):780-794.
[3]
Mahdi-Rogers M, Hughes RA. Epidemiology of chronic inflammatory neuropathies in southeast England[J]. Eur J Neurol, 2014, 21(1):28-33.
[4]
Latov N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies[J]. Nat Rev Neurol, 2014, 10(8):435-446.
[5]
Devic P, Petiot P, Mauguiere F. Diagnostic utility of somatosensory evoked potentials in chronic polyradiculopathy without electrodiagnostic signs of peripheral demyelination[J]. Muscle Nerve, 2016, 53(1):78-83.
[6]
Yiannikas C, Vucic S. Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy[J]. Muscle Nerve, 2008, 38(5):1447-1454.
[7]
Nevo Y, Topaloglu H. 88th ENMC international work-shop:childhood chronic inflammatory demyelinating polyneu-ropathy (including revised diagnostic criteria), Naarden, The Netherlands, December 8-10, 2000[J]. Neuromuscul Disord, 2002, 12(2):195-200.
Cruccu G, Aminoff MJ, Curio G, et al. Recommendations for the clinical use of somatosensory evoked potentials[J]. Clin Neurophysiol, 2008, 119(8):1705-1719.
[10]
Cornblath DR. Electrophysiology in Guillain-Barré syndrome[J]. Ann Neurol, 1990, 27(Suppl):S17-20.
Tsukamoto H, Sonoo M, Shimizu T. Segmental evaluation of the peripheral nerve using tibial nerve SSEPs for the diagnosis of CIDP[J]. Clin Neurophysiol, 2010, 121(1):77-84.
